Genetically Encoded Lipid-Polypeptide Hybrid Biomaterials that Exhibit Temperature Triggered Hierarchical Self-Assembly

Ashutosh Chilkoti (Inventor), Davoud Mozhdehi (Inventor), Kelli M. Luginbuhl (Inventor)

Research output: Patent

Abstract

Disclosed herein are conjugates including a fatty acid, a self-assembly domain, and a polypeptide, where the conjugates have phase transition behavior. Further disclosed are methods of using the conjugates to treat disease, methods of delivering an agent, and methods of preparing the conjugates.
Original languageEnglish (US)
StatePublished - Jul 19 2018

Fingerprint

Biocompatible Materials
Self assembly
Fatty Acids
Phase transitions
Lipids
Peptides
Temperature

Cite this

@misc{f3f7ccdad070483c92eef725840e313e,
title = "Genetically Encoded Lipid-Polypeptide Hybrid Biomaterials that Exhibit Temperature Triggered Hierarchical Self-Assembly",
abstract = "Disclosed herein are conjugates including a fatty acid, a self-assembly domain, and a polypeptide, where the conjugates have phase transition behavior. Further disclosed are methods of using the conjugates to treat disease, methods of delivering an agent, and methods of preparing the conjugates.",
author = "Ashutosh Chilkoti and Davoud Mozhdehi and Luginbuhl, {Kelli M.}",
year = "2018",
month = "7",
day = "19",
language = "English (US)",
type = "Patent",

}

TY - PAT

T1 - Genetically Encoded Lipid-Polypeptide Hybrid Biomaterials that Exhibit Temperature Triggered Hierarchical Self-Assembly

AU - Chilkoti, Ashutosh

AU - Mozhdehi, Davoud

AU - Luginbuhl, Kelli M.

PY - 2018/7/19

Y1 - 2018/7/19

N2 - Disclosed herein are conjugates including a fatty acid, a self-assembly domain, and a polypeptide, where the conjugates have phase transition behavior. Further disclosed are methods of using the conjugates to treat disease, methods of delivering an agent, and methods of preparing the conjugates.

AB - Disclosed herein are conjugates including a fatty acid, a self-assembly domain, and a polypeptide, where the conjugates have phase transition behavior. Further disclosed are methods of using the conjugates to treat disease, methods of delivering an agent, and methods of preparing the conjugates.

M3 - Patent

ER -